Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
6.18
+0.52 (9.19%)
Jun 30, 2026, 4:00 PM EDT - Market closed
Abeona Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 66.14 | 71.18 | -63.73 | -54.19 | -39.7 | -84.94 |
Depreciation & Amortization | 2.71 | 2.55 | 2 | 2.29 | 3.09 | 3.25 |
Stock-Based Compensation | 11.04 | 10.78 | 6.63 | 4.77 | 3.05 | 8.92 |
Other Adjustments | -78 | -155.45 | 3.47 | 11.91 | -4.04 | 25.37 |
Change in Receivables | 1.11 | -5.06 | 0.79 | -2.04 | 2.81 | -3 |
Changes in Inventories | -6.05 | -5.49 | - | - | - | - |
Changes in Accounts Payable | 1.6 | 6.54 | 1.51 | 2.04 | -4.11 | 0.83 |
Changes in Income Taxes Payable | -7.63 | 0.13 | - | - | - | - |
Changes in Unearned Revenue | 0.43 | - | - | - | - | - |
Changes in Other Operating Activities | 5.57 | -1.5 | -6.68 | -1.79 | -4.6 | -16.09 |
Operating Cash Flow | -77.73 | -76.33 | -56.02 | -37.01 | -43.48 | -65.67 |
Capital Expenditures | -7.51 | -7.98 | -2.45 | -0.33 | -0.13 | -4.15 |
Sale of Property, Plant & Equipment | - | - | 0.02 | 0.2 | 1.73 | - |
Purchases of Investments | -176.99 | -206.63 | -157.01 | -51.64 | -78.21 | -20.16 |
Proceeds from Sale of Investments | 137.91 | 167.27 | 120.2 | 51.97 | 52.64 | 90.38 |
Other Investing Activities | 76.18 | 152.37 | - | - | - | - |
Investing Cash Flow | 105.78 | 105.03 | -39.24 | 0.21 | -23.96 | 66.06 |
Long-Term Debt Issued | - | - | 20 | - | - | - |
Long-Term Debt Repaid | -2.22 | - | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | -2.22 | - | 20 | - | - | - |
Issuance of Common Stock | 10.5 | 26.08 | 85.63 | 37.39 | 46.96 | 24.86 |
Repurchase of Common Stock | -0.01 | -0.04 | -0.53 | -0.18 | -0.01 | - |
Net Common Stock Issued (Repurchased) | 10.5 | 26.04 | 85.1 | 37.21 | 46.96 | 24.86 |
Issuance of Preferred Stock | - | - | - | - | 22.47 | - |
Repurchase of Preferred Stock | - | - | - | - | -26.25 | - |
Net Preferred Stock Issued (Repurchased) | - | - | - | - | -3.78 | - |
Other Financing Activities | - | - | -0.96 | -0.15 | - | - |
Financing Cash Flow | 17.05 | 26.04 | 104.14 | 37.06 | 43.17 | 24.86 |
Net Cash Flow | 45.1 | 54.74 | 8.88 | 0.26 | -24.27 | 25.26 |
Free Cash Flow | -85.24 | -84.3 | -58.46 | -37.34 | -43.61 | -69.82 |
FCF Margin | -2506.97% | -1448.47% | - | -1066.86% | -3084.37% | -2327.20% |
Free Cash Flow Per Share | -1.39 | -1.27 | -1.42 | -1.75 | -5.55 | -17.73 |
Levered Free Cash Flow | -35.35 | 65.43 | -49.35 | -51.98 | -49.22 | -101.1 |
Unlevered Free Cash Flow | -110.38 | -95.07 | -69.83 | -44.93 | -56.66 | -106 |